News from ADA 2018

Discussion in 'Research' started by joshualevy, Jun 30, 2018.

  1. joshualevy

    joshualevy Approved members

    Dec 30, 2008
    The American Diabetes Association's Scientific Sessions for 2018 (called ADA2018 with hastag #2018ADA) just ended. I was not there, but did monitor twitter and other social media to get a feel for what was going on. As in previous years, it was about 90% type-2 and about 90% treatments (not cures), and of the remaining type-1/cure research, only a little was human trials of the type covered in this blog.

    So anyway, here is a huge list of links (mostly links to tweets) which I found interesting for one reason or other. I've tried to categorize them, and in a few cases, after the link, I've added a sentence or two about why I found them interesting.

    Summary web sites:

    Cure Related


    Meta-Dopa, which I need to blog about:

    Encapsulation for beta cells (animals, I think):

    Smart Insulin:


    Artificial Pancreas:
    There were lots more, but these really called out to me.

    General Interest:
    Average A1c by age:
    Vit D:
    T2D delays T1D?
    Mice vs. Humans:
    Gut not important?
    Patch Pump:
    Half Units Matter:
    Adjunct Therapy:
    Bariatric Surgery T1D:
    New Patch Pump:

    Lots of comorbid conditions:

    An attempt at a head-to-head comparison of islet transplants vs. Artificial Pancreas results. Interesting!

    The other form of bihormonal AP:
    Most bihormonal AP research uses insulin and glucagon, but this one uses insulin and pramlintide.

    Poster and Discussion:
    ADA and JDCA joint letter (later supported by the Berrie Center):
    These two guys (and many others) report dropping A1c, but no one calls them a cure:

    Interesting to me:
    Open Data Tools for Software Nerds:
    I found the next tweet interesting because Cure was in title, but treatment in contents. To me that shows a problem with "cure" research. Much of it is not really aimed at a cure:

    Low Carb: Carbohydrate Diets for Diabetes (ADA 2018)

    Atkinson honored (nPOD and much more):

    The "Most Obvious Research Conclusion Award"

    Joshua Levy
    publicjoshualevy at gmail dot com

    All the views expressed here are those of Joshua Levy, and nothing here is official JDRF, JDCA, or Bigfoot Biomedical news, views, policies or opinions. In my day job, I work in software for Bigfoot Biomedical. My daughter has type-1 diabetes and participates in clinical trials, which might be discussed here. My blog contains a more complete non-conflict of interest statement. Thanks to everyone who helps with the blog.
  2. katerinas

    katerinas Approved members

    Apr 20, 2010
    Thank you! will need time to read it all!

Share This Page


  1. This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
    By continuing to use this site, you are consenting to our use of cookies.
    Dismiss Notice